The major SSc-specific autoantibodies ACA, ATA and ARA are predictive of the clinical manifestations of limited disease with minimal internal organ involvement, pulmonary fibrosis and renal involvement respectively. This evidence concerns the gene ATM and pulmonary fibrosis.